BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 29680670)

  • 1. Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme.
    Feibelman KM; Fuller BP; Li L; LaBarbera DV; Geiss BJ
    Antiviral Res; 2018 Jun; 154():124-131. PubMed ID: 29680670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Sensitive and Robust High-Throughput Screening Assay for Inhibitors of the Chikungunya Virus nsP1 Capping Enzyme.
    Bullard-Feibelman KM; Fuller BP; Geiss BJ
    PLoS One; 2016; 11(7):e0158923. PubMed ID: 27427769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6'-β-Fluoro-Homoaristeromycin and 6'-Fluoro-Homoneplanocin A Are Potent Inhibitors of Chikungunya Virus Replication through Their Direct Effect on Viral Nonstructural Protein 1.
    Kovacikova K; Morren BM; Tas A; Albulescu IC; van Rijswijk R; Jarhad DB; Shin YS; Jang MH; Kim G; Lee HW; Jeong LS; Snijder EJ; van Hemert MJ
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approved drugs screening against the nsP1 capping enzyme of Venezuelan equine encephalitis virus using an immuno-based assay.
    Ferreira-Ramos AS; Li C; Eydoux C; Contreras JM; Morice C; Quérat G; Gigante A; Pérez Pérez MJ; Jung ML; Canard B; Guillemot JC; Decroly E; Coutard B
    Antiviral Res; 2019 Mar; 163():59-69. PubMed ID: 30639438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations on VEEV nsP1 relate RNA capping efficiency to ribavirin susceptibility.
    Rabah N; Ortega Granda O; Quérat G; Canard B; Decroly E; Coutard B
    Antiviral Res; 2020 Oct; 182():104883. PubMed ID: 32750467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Chikungunya virus by an adenosine analog targeting the SAM-dependent nsP1 methyltransferase.
    Mudgal R; Mahajan S; Tomar S
    FEBS Lett; 2020 Feb; 594(4):678-694. PubMed ID: 31623018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Class of Chikungunya Virus Small Molecule Inhibitors That Targets the Viral Capping Machinery.
    Abdelnabi R; Kovacikova K; Moesslacher J; Donckers K; Battisti V; Leyssen P; Langer T; Puerstinger G; Quérat G; Li C; Decroly E; Tas A; Marchand A; Chaltin P; Coutard B; van Hemert M; Neyts J; Delang L
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32340991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Use of Chikungunya Virus Replication Templates Utilizing Mammalian and Mosquito RNA Polymerase I-Mediated Transcription.
    Utt A; Rausalu K; Jakobson M; Männik A; Alphey L; Fragkoudis R; Merits A
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31217251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activity of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones against chikungunya virus targeting the viral capping nsP1.
    Gigante A; Gómez-SanJuan A; Delang L; Li C; Bueno O; Gamo AM; Priego EM; Camarasa MJ; Jochmans D; Leyssen P; Decroly E; Coutard B; Querat G; Neyts J; Pérez-Pérez MJ
    Antiviral Res; 2017 Aug; 144():216-222. PubMed ID: 28619679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palmitoylated Cysteines in Chikungunya Virus nsP1 Are Critical for Targeting to Cholesterol-Rich Plasma Membrane Microdomains with Functional Consequences for Viral Genome Replication.
    Bakhache W; Neyret A; Bernard E; Merits A; Briant L
    J Virol; 2020 May; 94(10):. PubMed ID: 32132240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection.
    Delang L; Li C; Tas A; Quérat G; Albulescu IC; De Burghgraeve T; Guerrero NA; Gigante A; Piorkowski G; Decroly E; Jochmans D; Canard B; Snijder EJ; Pérez-Pérez MJ; van Hemert MJ; Coutard B; Leyssen P; Neyts J
    Sci Rep; 2016 Aug; 6():31819. PubMed ID: 27545976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression.
    Kaur P; Thiruchelvan M; Lee RC; Chen H; Chen KC; Ng ML; Chu JJ
    Antimicrob Agents Chemother; 2013 Jan; 57(1):155-67. PubMed ID: 23275491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an ELISA assay for screening inhibitors against divalent metal ion dependent alphavirus capping enzyme.
    Kaur R; Mudgal R; Narwal M; Tomar S
    Virus Res; 2018 Sep; 256():209-218. PubMed ID: 29958924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus.
    Wada Y; Orba Y; Sasaki M; Kobayashi S; Carr MJ; Nobori H; Sato A; Hall WW; Sawa H
    Virology; 2017 May; 505():102-112. PubMed ID: 28236746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission.
    Wang YM; Lu JW; Lin CC; Chin YF; Wu TY; Lin LI; Lai ZZ; Kuo SC; Ho YJ
    Antiviral Res; 2016 Nov; 135():81-90. PubMed ID: 27742486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activity of silymarin against chikungunya virus.
    Lani R; Hassandarvish P; Chiam CW; Moghaddam E; Chu JJ; Rausalu K; Merits A; Higgs S; Vanlandingham D; Abu Bakar S; Zandi K
    Sci Rep; 2015 Jun; 5():11421. PubMed ID: 26078201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mRNA Capping by Venezuelan Equine Encephalitis Virus nsP1: Functional Characterization and Implications for Antiviral Research.
    Li C; Guillén J; Rabah N; Blanjoie A; Debart F; Vasseur JJ; Canard B; Decroly E; Coutard B
    J Virol; 2015 Aug; 89(16):8292-303. PubMed ID: 26041283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Insights into the Mechanisms of Action of Functionally Distinct Classes of Chikungunya Virus Nonstructural Protein 1 Inhibitors.
    Kovacikova K; Gorostiola González M; Jones R; Reguera J; Gigante A; Pérez-Pérez MJ; Pürstinger G; Moesslacher J; Langer T; Jeong LS; Delang L; Neyts J; Snijder EJ; van Westen GJP; van Hemert MJ
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0256620. PubMed ID: 33875421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses.
    Varghese FS; Kaukinen P; Gläsker S; Bespalov M; Hanski L; Wennerberg K; Kümmerer BM; Ahola T
    Antiviral Res; 2016 Feb; 126():117-24. PubMed ID: 26752081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.